Exosomes derived from Piwil2‑induced cancer stem cells transform fibroblasts into cancer‑associated fibroblasts.


Journal

Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756

Informations de publication

Date de publication:
04 2020
Historique:
received: 22 04 2019
accepted: 16 01 2020
pubmed: 24 4 2020
medline: 17 12 2020
entrez: 24 4 2020
Statut: ppublish

Résumé

Recently, several studies have demonstrated that cancer cell‑derived exosomes can facilitate tumor development and metastasis formation. However, the detailed function of exosomes released by cancer stem cells (CSCs) requires further investigation. The aim of the present study was to investigate the role of CSC‑derived exosomes in tumor development. For this purpose, Piwil2‑induced cancer stem cells (Piwil2‑iCSCs) were used as exosome‑generating cells, while fibroblasts (FBs) served as recipient cells. Exosomes were isolated by the ultracentrifugation of Piwil2‑iCSC‑conditioned medium and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis. To evaluate the effects of the exosomes on cell proliferation, migration and invasion, cell counting assay (CCK‑8), a wound healing assay and a Transwell assay were performed. Protein expression [matrix metalloproteinase (MMP)2, MMP9, α‑smooth muscle actin (α‑SMA) and vimentin and fibroblast‑activating protein (FAP)] was examined in FBs by western blot analysis. It was found that the Piwil2‑iCSC‑derived exosomes (Piwil2‑iCSC‑Exo) were oval or spherical, membrane‑coated vesicles with a uniform size (30‑100 nm in diameter). They are characterized by the surface expression of CD9, CD63, Hsp70 and Piwil2 proteins. Additional results from functional analyses revealed that Piwil2‑iCSC‑Exo enhanced the proliferative, migratory and invasive abilities of FBs, accompanied by the upregulated expression of MMP2 and MMP9. In addition, the increased expression of α‑SMA (P<0.05), vimentin (P<0.01 vs. control group, P<0.05 vs. PBS group) and FAP (P<0.001 vs. control group, P<0.01 vs. PBS group) following exposure to Piwil2‑iCSC‑Exo suggested that the exosomes induced FB transformation into cancer‑associated fibroblasts (CAFs). On the whole, the findings of this study demonstrate that Piwil2‑iCSC‑Exo induce the cancer‑associated phenotype in fibroblasts in vitro, suggesting that CSCs can promote tumor development through the modulation of the tumor microenvironment.

Identifiants

pubmed: 32323829
doi: 10.3892/or.2020.7496
pmc: PMC7057936
doi:

Substances chimiques

Argonaute Proteins 0
PIWIL2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1125-1132

Commentaires et corrections

Type : ErratumIn

Références

J Cell Biochem. 2016 Jul;117(7):1658-70
pubmed: 26640165
Int J Mol Sci. 2013 Jul 09;14(7):14240-69
pubmed: 23839094
Am J Stem Cells. 2014 Sep 05;3(2):46-62
pubmed: 25232505
Int Immunol. 2005 Jul;17(7):879-87
pubmed: 15908444
Cancer Res. 2011 Aug 1;71(15):5346-56
pubmed: 21670082
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
Cancer Res. 2005 Jul 1;65(13):5506-11
pubmed: 15994920
Cancer Biol Ther. 2012 Feb 1;13(3):123-9
pubmed: 22236832
Cancer Res. 2015 Mar 15;75(6):924-9
pubmed: 25604264
J Physiol Pharmacol. 2006 Nov;57 Suppl 7:5-16
pubmed: 17228093
Connect Tissue Res. 2015;56(5):414-25
pubmed: 26291921
Nature. 2011 Jan 20;469(7330):314-22
pubmed: 21248838
Int J Clin Exp Pathol. 2010 Mar 20;3(4):328-37
pubmed: 20490325
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6040-7
pubmed: 25337249
Blood. 2004 Aug 15;104(4):1183-90
pubmed: 15130945
Proteomics. 2017 Dec;17(23-24):
pubmed: 29115712
J Clin Invest. 2007 May;117(5):1175-83
pubmed: 17476347
Sci Rep. 2016 Dec 08;6:38750
pubmed: 27929118
J Cell Mol Med. 2008 Jan-Feb;12(1):67-96
pubmed: 18053092
Mol Cancer. 2017 Aug 25;16(1):143
pubmed: 28841829
Mol Cancer. 2017 Feb 16;16(1):41
pubmed: 28209166
PeerJ. 2018 May 29;6:e4763
pubmed: 29868251
Semin Cell Dev Biol. 2010 Feb;21(1):19-25
pubmed: 19857592
Int J Cancer. 2018 Mar 15;142(6):1086-1092
pubmed: 28983919
J Cell Sci. 2001 Dec;114(Pt 23):4143-51
pubmed: 11739647
J Immunol. 2009 Nov 15;183(10):6413-21
pubmed: 19841170
Matrix Biol. 2015 May-Jul;44-46:94-112
pubmed: 25912949
Nature. 2004 Nov 18;432(7015):332-7
pubmed: 15549095
Exp Biol Med (Maywood). 2012 Oct;237(10):1231-40
pubmed: 23104504
Stem Cells Int. 2018 Feb 28;2018:5416923
pubmed: 29681949
J Cancer. 2013;4(1):66-83
pubmed: 23386906
BMC Cancer. 2012 Jun 29;12:272
pubmed: 22748119
Cancer Biomark. 2013;13(5):315-21
pubmed: 24440970
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Oncotarget. 2016 Jan 26;7(4):3993-4008
pubmed: 26675257
Crit Rev Oncol Hematol. 2013 Oct;88(1):117-22
pubmed: 23602800
Mol Cancer. 2014 Jan 31;13:18
pubmed: 24479681
Cancer Metastasis Rev. 2009 Jun;28(1-2):177-83
pubmed: 19259624
Matrix Biol. 2015 May-Jul;44-46:255-63
pubmed: 25701651
Am J Pathol. 2004 Apr;164(4):1369-77
pubmed: 15039224
Tumour Biol. 2016 Sep;37(9):12169-12180
pubmed: 27220495
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Cell Stem Cell. 2014 Mar 6;14(3):275-91
pubmed: 24607403
Int J Clin Exp Pathol. 2012;5(4):315-25
pubmed: 22670175
Am J Transl Res. 2010 Mar 25;2(2):156-69
pubmed: 20407605
Lab Invest. 2018 Sep;98(9):1133-1142
pubmed: 29967342
Semin Reprod Med. 2013 Jan;31(1):5-13
pubmed: 23329631
Liver Transpl. 2010 May;16(5):621-30
pubmed: 20440771
Stem Cells. 2007 Mar;25(3):707-11
pubmed: 17138959
Clin Cancer Res. 2005 Apr 1;11(7):2492-501
pubmed: 15814625
Nat Cell Biol. 2012 Oct;14(10):1036-45
pubmed: 22983114
J Clin Oncol. 2009 Nov 1;27(31):5287-97
pubmed: 19738110
Clin Transl Oncol. 2019 Feb;21(2):152-159
pubmed: 30051211
Cell Physiol Biochem. 2015;37(3):1210-8
pubmed: 26418253
Oncotarget. 2017 Feb 14;8(7):12259-12271
pubmed: 28103575

Auteurs

Dan Zhang (D)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Dian Li (D)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Lianju Shen (L)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Dong Hu (D)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Bo Tang (B)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Wenhao Guo (W)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Zhang Wang (Z)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Zhaoxia Zhang (Z)

Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, P.R. China.

Guanghui Wei (G)

Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China.

Dawei He (D)

Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH